The success of BoneOscopy relies on the interdisciplinarity of its consortium, which comprises institutions with key expertise in multiple disciplines such as bioengineering, biology, physics, instrumentation, robotics and clinical PRT. If achieved, the proposed science-to-technology breakthrough will have a transformative impact on current cancer treatment by providing a safe, personalised and quantitative measure of daily treatment efficacy, thereby contributing to the global fight against cancer.